Suppr超能文献

囊性纤维化患儿粪便稠度与临床变量的相关性:BONUS 研究结果。

Association between stool consistency and clinical variables among infants with cystic fibrosis: Findings from the BONUS study.

机构信息

Associate Professor, Division Gastroenterology, Hepatology and Nutrition, Children's Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, GA, USA.

Lead Biostatistician, Research Administration, Children's Medical Center Dallas, Dallas, TX, USA.

出版信息

J Cyst Fibros. 2022 Sep;21(5):830-836. doi: 10.1016/j.jcf.2022.05.003. Epub 2022 May 16.

Abstract

BACKGROUND

Concerns related to stool consistency are common in the first year of life among children with cystic fibrosis (CF). However, normal stool patterns for infants with CF have not been described.

METHODS

Secondary analysis was completed from the previously described BONUS cohort which followed 231 infants with CF through the first 12 months of life. Pain, stool category, stool frequency, feeding type, PERT dose, acid suppression medication, antibiotics usage, stool softener usage and fecal calprotectin were described at 3, 6, and 12 months. Repeated measure ANOVA was used to test the difference in mean stool number. Generalized linear mixed models were used to investigate the relationship between stool characteristics and various factors.

RESULTS

The frequency of constipation was stable throughout the first year of life (10-13%) while watery stool significantly decreased from 21.3% at 3 months to 5.8% at 12 months (p=<0.001). The number of stools at months 6 (mean=2.40) and 12 (mean=2.50) are significantly lower than in month 3 (mean=2.83), p<0.025. Exclusive breast feeding was associated with an increased risk for constipation (OR=2.64  [1.60-4.37], p = 0.002) while exclusive formula feeding and acid suppression was associated with decreased risk for constipation (OR=0.40  [0.26-0.61], p=<0.0001 and OR=0.59  [0.39-0.89], p = 0.01 respectively). Pain was not significantly associated with stool consistency.

CONCLUSION

Stool frequency and consistency evolves in infant with CF in a fashion similar to that reported in non-CF infants over the first year. Constipation was not associated with pain and was less common among infants receiving acid suppression or exclusively formula feeding.

摘要

背景

囊性纤维化(CF)患儿在生命的第一年常出现与粪便稠度相关的问题。然而,尚未对 CF 患儿的正常粪便模式进行描述。

方法

对先前描述的 BONUS 队列进行二次分析,该队列对 231 例 CF 婴儿进行了为期 12 个月的随访。在 3、6 和 12 个月时描述了疼痛、粪便分类、粪便频率、喂养类型、PERT 剂量、抑酸药物、抗生素使用、粪便软化剂使用和粪便钙卫蛋白。采用重复测量方差分析检验平均粪便数量的差异。采用广义线性混合模型探讨粪便特征与各种因素的关系。

结果

便秘的频率在整个第一年保持稳定(10-13%),而稀便则从 3 个月时的 21.3%显著下降到 12 个月时的 5.8%(p<0.001)。6 个月(均值=2.40)和 12 个月(均值=2.50)的粪便数量明显低于 3 个月(均值=2.83),p<0.025。纯母乳喂养与便秘风险增加相关(OR=2.64 [1.60-4.37],p=0.002),而纯配方奶喂养和抑酸治疗与便秘风险降低相关(OR=0.40 [0.26-0.61],p<0.0001 和 OR=0.59 [0.39-0.89],p=0.01)。疼痛与粪便稠度无显著相关性。

结论

CF 患儿的粪便频率和稠度在第一年的变化与非 CF 婴儿的变化相似。便秘与疼痛无关,在接受抑酸治疗或纯配方奶喂养的婴儿中较少见。

相似文献

4
Calprotectin in cystic fibrosis.囊性纤维化中的钙卫蛋白。
BMC Pediatr. 2014 May 29;14:133. doi: 10.1186/1471-2431-14-133.

本文引用的文献

1
2.1 Breastfeeding.2.1母乳喂养。
World Rev Nutr Diet. 2022;124:133-138. doi: 10.1159/000516700. Epub 2022 Mar 3.
6
Pancreatic enzyme replacement therapy for people with cystic fibrosis.针对囊性纤维化患者的胰酶替代疗法。
Cochrane Database Syst Rev. 2020 Aug 5;8(8):CD008227. doi: 10.1002/14651858.CD008227.pub4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验